基因组变异解剖揭示了MUC4突变作为肺腺癌局部复发的潜在驱动因素
Chongze Yuan1,2,3, Xingxin Yao1,2,3, Pengfei Dai4
1Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
Translational lung cancer research
|June 16, 2023
概括
肺腺癌 (LUAD) 的基因组变化在复发期间发生变化. 像MUC4这样的关键突变可能通过激活特定的信号通路来驱动LUAD复发,从而提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 肺腺癌 (LUAD) 是最常见的组织学类型的肺癌.
- 尽管预后有所改善,但近一半的LUAD患者经历了切除后的复发.
- 了解推动LUAD复发的基因组机制对于改善患者的治疗结果至关重要.
研究的目的:
- 调查原发性和复发性肺腺癌瘤中的基因组变化.
- 确定与LUAD复发相关的特定基因和途径.
- 探索辅助治疗对瘤演变的影响.
主要方法:
- 在41名患者的41个原发性和43个复发性LUAD瘤上进行了整体外体序列测序 (WES).
- 分析了体质突变,拷贝数变异和结构变异.
- 使用MutsigCV识别显著突变和复发特异性基因.
主要成果:
- 在原发性和复发性瘤中确定了包括EGFR,MUC4和TP53在内的显著突变基因.
- 在MUC17,KRAS和ZNF家族中发现复发特异性突变.
- 在复发瘤中观察到高度激活的ErbB信号传递,MAPK和细胞循环通路,可能导致复发.
- MUC4具有高度突变,并被确定为激活ErbB信号通路的潜在驱动基因.
结论:
- 在复发期间,LUAD的基因组格局会发生演变,为瘤细胞的生存创造一个更有利的环境.
- 确定了MUC4作为潜在的驱动突变和LUAD复发的治疗标.
- 需要进一步的研究来阐明特定突变在LUAD复发中的特定功能和作用.
相关概念视频
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancers Originate from Somatic Mutations in a Single Cell
12.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.1K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


